| Dr Achal Patel, MD | |
|
5519 Doctors Dr, Edinburg, TX 78539-5563 | |
| (956) 362-8500 | |
| (956) 362-8505 |
| Full Name | Dr Achal Patel |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 13 Years |
| Location | 5519 Doctors Dr, Edinburg, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265723019 | NPI | - | NPPES |
| BP1-0040984 | Other | TX | UTMB POSTGRADUATE TRAINING PERMIT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | R4302 (Texas) | Primary |
| 207T00000X | Neurological Surgery | BP1-0040984 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doctors Hospital At Renaissance | Edinburg, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Renaissance Medical Foundation | 1153409867 | 86 |
News Archive
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that Prof. Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx's BL-8040 as a treatment for chronic myeloid leukemia (CML) in a Phase 1/2 clinical study.
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
Administration officials will "try to encourage reluctant states" to move forward with health exchanges, even as time appears to be running out, Reuters reports. Also in the news, consumer representatives from the National Association of Insurance Commissioners offered state and federal officials suggestions about how they should write regulations to implement the health law's key consumer protections.
Millions of vulnerable people are to be offered a COVID-19 booster vaccine from next week as the government confirms it has accepted the final advice from the independent Joint Committee on Vaccination and Immunisation (JCVI).
› Verified 7 days ago
| Entity Name | Renaissance Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467633867 PECOS PAC ID: 1153409867 Enrollment ID: O20080422000326 |
News Archive
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that Prof. Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx's BL-8040 as a treatment for chronic myeloid leukemia (CML) in a Phase 1/2 clinical study.
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
Administration officials will "try to encourage reluctant states" to move forward with health exchanges, even as time appears to be running out, Reuters reports. Also in the news, consumer representatives from the National Association of Insurance Commissioners offered state and federal officials suggestions about how they should write regulations to implement the health law's key consumer protections.
Millions of vulnerable people are to be offered a COVID-19 booster vaccine from next week as the government confirms it has accepted the final advice from the independent Joint Committee on Vaccination and Immunisation (JCVI).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Achal Patel, MD Po Box 749, Pharr, TX 78577-1614 Ph: (956) 362-8500 | Dr Achal Patel, MD 5519 Doctors Dr, Edinburg, TX 78539-5563 Ph: (956) 362-8500 |
News Archive
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that Prof. Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx's BL-8040 as a treatment for chronic myeloid leukemia (CML) in a Phase 1/2 clinical study.
XBiotech announced today enrollment of the first patient into its Phase III trial of Xilonix. The Pivotal study is designed to improve health and survival of late stage colorectal cancer patients with associated cachexia.
Administration officials will "try to encourage reluctant states" to move forward with health exchanges, even as time appears to be running out, Reuters reports. Also in the news, consumer representatives from the National Association of Insurance Commissioners offered state and federal officials suggestions about how they should write regulations to implement the health law's key consumer protections.
Millions of vulnerable people are to be offered a COVID-19 booster vaccine from next week as the government confirms it has accepted the final advice from the independent Joint Committee on Vaccination and Immunisation (JCVI).
› Verified 7 days ago
Dr. Jacinto I Manon, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5519 Doctors Dr, Edinburg, TX 78539 Phone: 956-362-8500 Fax: 956-362-8505 | |
Michael Burke, MD,FACS,FAAP Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2821 Michaelangelo Dr, Ste 200, Edinburg, TX 78539 Phone: 956-362-8215 Fax: 956-362-8219 | |
Dr. Juan Ed Torres-reveron, M.D./ PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5519 Doctors Dr, Edinburg, TX 78539 Phone: 956-362-8500 Fax: 956-362-8505 | |
Patricia Fernandez, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2821 Michaelangelo Dr Ste 304, Edinburg, TX 78539 Phone: 956-362-8501 Fax: 956-362-8505 | |
Dr. Jaime Gasco-tamarit, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4302 S Sugar Rd Ste 100, Edinburg, TX 78539 Phone: 956-292-0570 Fax: 956-292-0102 | |
Dr. Inad Badreddin Atassi, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5519 Doctors Dr, Edinburg, TX 78539 Phone: 956-362-8500 Fax: 956-362-8505 |